Although 5-Amino-1MQ is still considered an emerging longevity compound, its ability to inhibit NNMT positions it as one of the most promising tools for preserving NAD+ and supporting mitochondrial health, especially when combined with NAD+ therapy
Related products Amalaki $ 130,75 $ 224,14Price range: $ 130,75 through $ 224,14 Active substance: Amalaki (Emblica officinalis) Extract Arcalion $ 163,80 $ 327,59Price range: $ 163,80 through $ 327,59 Active substance: Sulbutiamine Beclamethasone $ 168,11 $ 574,72Price range: $ 168,11 through $ 574,72 Active substance: Beclomethasone Dipropionate Ciprodex Ophthalmic Solution $ 113,51 $ 170,98Price range: $ 113,51 through $ 170,98 Active substance: Ciprofloxacin, Dexamethasone Deflazacort $ 25,86 $ 393,68Price range: $ 25,86 through $ 393,68 Active substance: Deflazacort Folic Acid $ 120,69 $ 362,07Price range: $ 120,69 through $ 362,07 Active substance: Folic Acid
That said, BPC-157 is still considered an investigational compound and not approved by the FDA
Our medical team reviews your health history before starting treatment to ensure safety